论文部分内容阅读
目的:分析对比埃索美拉唑与奥美拉唑治疗胃溃疡的临床效果及安全性。方法:选取2013年1月至2013年12月期间在我院接受治疗的胃溃疡患者80例,并将其随机分为观察组与对照组。观察组患者以埃索美拉唑为主进行治疗,对照组患者以奥美拉唑为主进行治疗。6周后对两组患者的治疗效果进行比较。结果:观察组患者的总有效率为85%,对照组患者的总有效率为80%。两组数据差异显著,结果具有统计意义(p<0.05)。结论:埃索美拉唑与奥美拉唑均是治疗胃溃疡的常用药物,但相比而言,埃索美拉唑具有更明显的治疗优势。因此临床上更推崇以埃索美拉唑治疗胃溃疡。
Objective: To analyze the clinical effects and safety of esomeprazole versus omeprazole in the treatment of gastric ulcer. Methods: 80 patients with gastric ulcer treated in our hospital from January 2013 to December 2013 were selected and randomly divided into observation group and control group. Patients in the observation group were mainly treated with esomeprazole, and patients in the control group were mainly treated with omeprazole. After 6 weeks the treatment effect of the two groups was compared. Results: The total effective rate in the observation group was 85% and that in the control group was 80%. Significant differences between the two groups of data, the results were statistically significant (p <0.05). Conclusion: Both esomeprazole and omeprazole are commonly used in the treatment of gastric ulcer. However, esomeprazole has more obvious therapeutic advantages compared with esomeprazole. Therefore, more esteem clinically esomeprazole treatment of gastric ulcer.